Explicit modeling of antibody levels for infectious disease simulations in the context of SARS-CoV-2
Description
Measurable levels of immunoglobulin G antibodies develop after infections with and vaccinations against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). These antibody levels are dynamic: due to waning, antibody levels will drop over
